Sidley Austin represented Resolian in the transaction. Resolian, a global bioanalytical contract research organization (CRO), announced the acquisition of Denali Medpharma (Denali), a leading China-based bioanalytical CRO....
This content is for Standard 1 Year members only. LoginJoin Now